369 related articles for article (PubMed ID: 28619230)
1. Innovative financing instruments for global health 2002-15: a systematic analysis.
Atun R; Silva S; Knaul FM
Lancet Glob Health; 2017 Jul; 5(7):e720-e726. PubMed ID: 28619230
[TBL] [Abstract][Full Text] [Related]
2. Innovative financing for health: what is truly innovative?
Atun R; Knaul FM; Akachi Y; Frenk J
Lancet; 2012 Dec; 380(9858):2044-9. PubMed ID: 23102585
[TBL] [Abstract][Full Text] [Related]
3. Financing of global health: tracking development assistance for health from 1990 to 2007.
Ravishankar N; Gubbins P; Cooley RJ; Leach-Kemon K; Michaud CM; Jamison DT; Murray CJ
Lancet; 2009 Jun; 373(9681):2113-24. PubMed ID: 19541038
[TBL] [Abstract][Full Text] [Related]
4. Development assistance for health: past trends, associations, and the future of international financial flows for health.
Dieleman JL; Schneider MT; Haakenstad A; Singh L; Sadat N; Birger M; Reynolds A; Templin T; Hamavid H; Chapin A; Murray CJ
Lancet; 2016 Jun; 387(10037):2536-44. PubMed ID: 27086170
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
[TBL] [Abstract][Full Text] [Related]
6. Innovative financing for HIV response in sub-Saharan Africa.
Atun R; Silva S; Ncube M; Vassall A
J Glob Health; 2016 Jun; 6(1):010407. PubMed ID: 27231543
[TBL] [Abstract][Full Text] [Related]
7. Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study.
Haakenstad A; Moses MW; Tao T; Tsakalos G; Zlavog B; Kates J; Wexler A; Murray CJL; Dieleman JL
Lancet HIV; 2019 Jun; 6(6):e382-e395. PubMed ID: 31036482
[TBL] [Abstract][Full Text] [Related]
8. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
Global Burden of Disease Health Financing Collaborator Network
Lancet; 2020 5-11 Sep; 396(10252):693-724. PubMed ID: 32334655
[TBL] [Abstract][Full Text] [Related]
9. Sources and Focus of Health Development Assistance, 1990-2014.
Dieleman JL; Graves C; Johnson E; Templin T; Birger M; Hamavid H; Freeman M; Leach-Kemon K; Singh L; Haakenstad A; Murray CJ
JAMA; 2015 Jun; 313(23):2359-68. PubMed ID: 26080340
[TBL] [Abstract][Full Text] [Related]
10. The Global Fund's resource allocation decisions for HIV programmes: addressing those in need.
Avdeeva O; Lazarus JV; Aziz MA; Atun R
J Int AIDS Soc; 2011 Oct; 14():51. PubMed ID: 22029667
[TBL] [Abstract][Full Text] [Related]
11. An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries.
Vujicic M; Weber SE; Nikolic IA; Atun R; Kumar R
Health Policy Plan; 2012 Dec; 27(8):649-57. PubMed ID: 22333685
[TBL] [Abstract][Full Text] [Related]
12. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
[TBL] [Abstract][Full Text] [Related]
13. GAVI funding meeting exceeds expectations.
Usher AD
Lancet; 2011 Jun; 377(9784):2165-6. PubMed ID: 21714163
[No Abstract] [Full Text] [Related]
14. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
Global Burden of Disease 2020 Health Financing Collaborator Network
Lancet; 2021 Oct; 398(10308):1317-1343. PubMed ID: 34562388
[TBL] [Abstract][Full Text] [Related]
15. Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targets.
Floyd K; Fitzpatrick C; Pantoja A; Raviglione M
Lancet Glob Health; 2013 Aug; 1(2):e105-e115. PubMed ID: 25104145
[TBL] [Abstract][Full Text] [Related]
16. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
Kerouedan D
Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
[TBL] [Abstract][Full Text] [Related]
17. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
Schmidt-Traub G
Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
[TBL] [Abstract][Full Text] [Related]
18. Global health development assistance remained steady in 2013 but did not align with recipients' disease burden.
Dieleman JL; Graves CM; Templin T; Johnson E; Baral R; Leach-Kemon K; Haakenstad AM; Murray CJ
Health Aff (Millwood); 2014 May; 33(5):878-86. PubMed ID: 24714869
[TBL] [Abstract][Full Text] [Related]
19. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
[TBL] [Abstract][Full Text] [Related]
20. Costs of eliminating malaria and the impact of the global fund in 34 countries.
Zelman B; Kiszewski A; Cotter C; Liu J
PLoS One; 2014; 9(12):e115714. PubMed ID: 25551454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
